{"status": "OK", "response": {"docs": [{"type_of_material": "Article", "blog": [], "news_desk": null, "lead_paragraph": "WASHINGTON, July 28 (AP) --A Food and Drug Administration official revealed today that the agency has been considering changes in its regulations concerning distribution of experimental drugs to reduce hazards from their use.", "headline": {"main": "U.S. Considering Regulations To Reduce Peril of New Drugs; Move by Food and Drug Administration Spurred by Thalidomide Birth Defects --Controls Are Limited at Present"}, "abstract": "thalidomide effects spur Food and Drug Adm to study tightening testing procedures for new drugs; Merrell co says drive to reach drs who got thalidomide indicates little if any of drug is still extant; Prof Taussig forthcoming article on thalidomide urges tighter testing procedures; NYC Health Dept repts it has reached all but 1 of 14 drs who got drug", "print_page": "44", "word_count": 1377, "_id": "4fc4153245c1498b0d8fd460", "snippet": "WASHINGTON, July 28 (AP) --A Food and Drug Administration official revealed today that the agency has been considering changes in its regulations concerning distribution of experimental drugs to reduce hazards from their use.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/abstract.html?res=9E01EFDB153EE036A0575AC2A9619C946391D6CF", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS AND DRUG TRADE"}, {"name": "subject", "value": "SLEEPING DRUGS"}], "byline": null, "document_type": "article", "pub_date": "1962-07-29T00:00:00Z", "section_name": null}], "meta": {"hits": 1, "offset": 0, "time": 33}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}